Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

Item
http://www.wikidata.org/entity/Q33492180
Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology GroupPrognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan.Autologous and allogeneic blood stem cell transplantation: potential advantage of blood-over marrow-derived stem cell grafts.Bone marrow transplants from peripheral blood.Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation.
P2860

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

Item
http://www.wikidata.org/entity/Q33492180
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Use of peripheral-blood progen ...... cyclophosphamide chemotherapy.
@ast
Use of peripheral-blood progen ...... cyclophosphamide chemotherapy.
@en
type
label
Use of peripheral-blood progen ...... cyclophosphamide chemotherapy.
@ast
Use of peripheral-blood progen ...... cyclophosphamide chemotherapy.
@en
prefLabel
Use of peripheral-blood progen ...... cyclophosphamide chemotherapy.
@ast
Use of peripheral-blood progen ...... cyclophosphamide chemotherapy.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Use of peripheral-blood progen ...... cyclophosphamide chemotherapy.
@en
P2093
P304
P31
P356
10.1200/JCO.1993.11.8.1583
P407
P433
P478
P577
P698